D.C. Mun. Regs. tit. 17, r. 17-6599

Current through Register Vol. 71, No. 50, December 13, 2024
Rule 17-6599 - DEFINITIONS
6599.1

As used in this chapter, the following terms have the meanings ascribed:

ACPE - The Accreditation Council for Pharmaceutical Education.

Act - The District of Columbia Health Occupation Revision Act of 1985 ("Act"), effective March 25, 1986 (D.C. Law 6-99; D.C. Official Code § 3-1201.01 et seq.)

Adulterated drug or device - an adulterated drug or device as defined in § 501 of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 351.

Applicant - a person applying for a license to practice pharmacy under this chapter.

Board - the Board of Pharmacy, established by § 208 of the Act, D.C. Code § 2-3302.8 (1988).

Coded prescription - a prescription employing words and symbols chosen by the prescriber and a cooperating pharmacist for secrecy from other pharmacists.

Contact hour - a period of at least fifty (50) minutes of instruction in a continuing education program. One (1) contact hour equals one-tenth (0.1) of a continuing education credit.

Department - The District of Columbia Department of Health.

Director - The Director of the District of Columbia Department of Health.

Distribution - the actual, constructive, or attempted transfer from one person to another, other than by administering or dispensing, of a drug or medical device whether or not there is an agency relationship.

Enrolled in a pharmacy program - In order to be considered enrolled in a school of pharmacy, a person shall not be absent from school for more than two (2) consecutive semesters or three (3) consecutive quarters.

FPGEC - Foreign Pharmacy Graduate Examination Committee.

Home-Study and other Mediated Instruction - Covers all continuing education activities, including Internet courses, which do not provide for direct interaction between faculty and participants and may include audio tapes, video tapes, cable television, computer assisted instruction, journal articles, monographs, etc.

MPJE - Multistate Pharmacy Jurisprudence Examination for the District of Columbia

NABP - National Association of Boards of Pharmacy

NAPLEX - North American Pharmacist Licensure Examination

Pharmacist - a person licensed to practice pharmacy under the Act.

Pharmacy intern - a person registered in the District to practice pharmacy under the direct supervision of a pharmacist and who is fulfilling internship (sometimes called externship) requirements in accordance with the chapter.

Preceptor - means a pharmacist licensed in good standing in the District, who has been approved by the Board to supervise the pre-licensure professional practice of a pharmacy intern.

Prescriber - a health professional licensed in the United States and authorized by law to prescribe the particular drug or device.

Prescription Drug - one of the following drugs:

(a) A drug which under federal law is required, prior to being dispensed or delivered, to be labeled in substance with either of the following statements:
(1) "Caution: Federal law prohibits dispensing without prescription."; or
(2) "Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.";
(b) A drug which is required by any applicable federal or District law or regulation to be dispensed on prescription only; or
(c) A drug that is restricted to use by health professional and allied practitioners for research.

Registration - a document issued by the Board authorizing a pharmacy intern to do pre-licensure professional practice in the District with a designated preceptor.

Supervised practice letter - document issued by the Board authorizing the individual to practice the same scope of duties as a pharmacy intern under the supervision of a pharmacist licensed under the Act, while his or her application for licensure in the District of Columbia is pending or as otherwise authorized by the Board.

6599.2

The definitions in § 4099 of chapter 40 of this title are incorporated by reference and made applicable to this chapter.

D.C. Mun. Regs. tit. 17, r. 17-6599

Final Rulemaking published at 36 DCR 6243, 6253 (September 1, 1989); as amended by Final Rulemaking published at 55 DCR 4330 (April 18, 2008)